Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to -$14000.0.

  • Bio Green Med Solution's Other Non Operating Income fell 80000.0% to -$14000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$113000.0, marking a year-over-year increase of 6220.74%. This contributed to the annual value of -$54000.0 for FY2024, which is 8695.65% up from last year.
  • As of Q3 2025, Bio Green Med Solution's Other Non Operating Income stood at -$14000.0, which was down 80000.0% from -$3000.0 recorded in Q2 2025.
  • In the past 5 years, Bio Green Med Solution's Other Non Operating Income ranged from a high of $1.3 million in Q1 2022 and a low of -$356000.0 during Q4 2023
  • Its 5-year average for Other Non Operating Income is $93000.0, with a median of $9500.0 in 2021.
  • Per our database at Business Quant, Bio Green Med Solution's Other Non Operating Income soared by 296666.67% in 2022 and then crashed by 900000.0% in 2023.
  • Quarter analysis of 5 years shows Bio Green Med Solution's Other Non Operating Income stood at $9000.0 in 2021, then tumbled by 55.56% to $4000.0 in 2022, then plummeted by 9000.0% to -$356000.0 in 2023, then soared by 70.22% to -$106000.0 in 2024, then surged by 86.79% to -$14000.0 in 2025.
  • Its Other Non Operating Income was -$14000.0 in Q3 2025, compared to -$3000.0 in Q2 2025 and $10000.0 in Q1 2025.